The Magnum Ice Cream Company N.V.
MICCThe Magnum Ice Cream Company N.V.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.
The price is between stages. Underneath, the last four quarters read deteriorating — profit −223.1% year on year, and 177% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
The Magnum Ice Cream Company N.V. trades at $18.3, between stages. It sits at 84% of a 52-week range of $13 to $19. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 7 straight weeks.
Today the stock is between stages. At $18.3 it trades near its long-run average and sits at 84% of its 52-week range ($13–$19).
Against the market, two honest reads. Cumulative: over the last 7 months the stock moved +15% while the S&P 500 moved +13% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 7 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
The Magnum Ice Cream Company N.V. trades at 54.2× P/E, against too little history to rank. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 54.2× is against too little history to rank. This is a comparison against the stock's own history — not a claim about what it is worth.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
The Magnum Ice Cream Company N.V. reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 4 quarters across 1 curve, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −0.5% | +1.7% | — | — |
| Profit | −47.5% | −16.4% | — | — |
4-Factor Sector Score
44.6/100 — rank 30 of 30 in Packaged Foods · 18% evidence confidence · provisional, ranked below fully-evidenced peers
The Magnum Ice Cream Company N.V. scores 44.6 out of 100 against the 30 companies it is compared with in Packaged Foods, ranking 30. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 16.7 + 9.2 + 8.7 + 10 = 44.6. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
The Magnum Ice Cream Company N.V. reported $3.4 B of revenue in the Dec 25 quarter, −3.9% year on year. Over 3 years it has compounded at 1.7% a year. The last full year, FY25, came in at $7.9 B. The last four reported quarters add to $15.8 B.
FY25 revenue came in at $7.9 B (−0.5% on the year), capping 3 years at 1.7% compound. The latest quarter (Dec 25) printed $3.4 B, −3.9% year on year.
Pace check: the last four quarters averaged −0.7% growth against the decade's 1.7% — the current year is running slower than its own long-run rate.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
The Magnum Ice Cream Company N.V.'s operating margin is 0.9% in the Dec 25 quarter, −3.6 percentage points against the same quarter a year ago. Across 4 fiscal years the operating margin has ranged 7.6% to 9.9%. The current quarter is running below every full year in that window.
The latest quarter's operating margin is 0.9%, −3.6 pp against the same quarter a year ago. Across 4 fiscal years the operating margin has ranged 7.6%–9.9%.
Why: the numbers show the operating margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
The Magnum Ice Cream Company N.V. posted a net loss of $0.2 B in the Dec 25 quarter. Full-year FY25 profit was $0.3 B. The 3-year compound rate is −16.4%. That loss is 4.7% of the quarter's revenue.
Dec 25 profit was $−0.2 B, −223.1% year on year. On the full year, FY25 printed $0.3 B (−47.5%), and the 3-year compound rate is −16.4%.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 177% of The Magnum Ice Cream Company N.V.'s reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $0.5 B of operating cash against $0.3 B of profit. After $0.4 B of capital spending, $0.1 B was left as free cash.
FY25: operating cash of $0.5 B against reported profit of $0.3 B, leaving free cash of $0.1 B after $0.4 B of capital spending. Across the last 3 fiscal years the conversion rate is 177% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
The Magnum Ice Cream Company N.V. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $1.0 B over the last 3 years. Averaged over those years that is 4.2% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $1.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
The Magnum Ice Cream Company N.V. earns a ROE of 49% in FY25. That is up from a trough of 20% in FY23. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 3.9% net margin on 1.06× asset turns.
FY25 ROE is 49%, recovered from a FY23 trough of 20% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): 3.9% net margin × 1.06× asset turns × 11.89× balance-sheet leverage ≈ 49.2% on equity. Margin does its share; leverage is a meaningful part of the equation.
Dividend
The Magnum Ice Cream Company N.V. pays no dividend. Across the last 4 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
The Magnum Ice Cream Company N.V. does not currently pay a dividend. Across the last 4 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Debt-to-equity is 3.43 at the latest reading — carrying real leverage; a full borrowings history is not in our numbers.
We hold only the latest reading here: a debt-to-equity of 3.43 — a level of leverage that amplifies both the returns above and the risk. A year-by-year borrowings ladder is not in our numbers for this stock, so we say that rather than draw a chart we cannot support.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
2.5% of The Magnum Ice Cream Company N.V.'s tradable float is currently sold short — some money is positioned against it. At typical trading volumes those positions would take about 7.8 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 2.5% of the float is sold short, and at typical trading volumes it would take about 7.8 days to buy those positions back. Some money is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
The Magnum Ice Cream Company N.V.: the Z-score reads 1.75. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits inside the distress zone. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
🚨 Why it matters: a Z-score of 1.75 is inside the distress zone — the balance sheet is a real risk, not a detail.
The safety line in one sentence: the Z-score reads 1.75.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Seneca Foods CorporationSENEA | 65.4/100Thin evidence · provisional60% evidence | TURNING | 22.9/35 Revenue 5.1% · PAT 100% · OPM change 5.4 pp 53% evidence | 10.8/25 ROCE 2.3% · OPM 6% 57% evidence | 15.7/20 P/E 9.1× · PEG 0.28 65% evidence | 16.0/20 RS sector 25.6% · RS bench 18.5% · 1Y 69%5 of 12 weeks ahead 70% evidence |
| Exact sum: 22.9 + 10.8 + 15.7 + 16 = 65.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 2Darling Ingredients Inc.DAR | 62.8/100Thin evidence · provisional56% evidence | ASLEEP | 23.2/35 Revenue — · PAT — · OPM change 9.5 pp 39% evidence | 17.1/25 ROCE 12% · OPM 14.6% 76% evidence | 9.8/20 P/E 15.2× · PEG — 15% evidence | 12.7/20 RS sector 22.3% · RS bench 16.1% · 1Y 96.4%1 of 12 weeks ahead 100% evidence |
| Exact sum: 23.2 + 17.1 + 9.8 + 12.7 = 62.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 3Central Garden & Pet CompanyCENT | 62.5/100Mixed-positive evidence66% evidence | BREAKING OUT | 19.7/35 Revenue 0.2% · PAT 37.9% · OPM change 0.8 pp 53% evidence | 13.6/25 ROCE 8.8% · OPM 12.6% 57% evidence | 15.1/20 P/E 12.1× · PEG 0.25 65% evidence | 14.1/20 RS sector 15.4% · RS bench 8.4% · 1Y 29.3%7 of 12 weeks ahead 100% evidence |
| Exact sum: 19.7 + 13.6 + 15.1 + 14.1 = 62.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Mama's Creations, Inc.MAMA | 59.9/100Mixed-positive evidence81% evidence | BREAKING OUT | 24.5/35 Revenue 46.5% · PAT 50% · OPM change 0.5 pp 83% evidence | 11.3/25 ROCE 5.3% · OPM 5% 76% evidence | 5.6/20 P/E 94.6× · PEG 2.6 65% evidence | 18.5/20 RS sector 30.7% · RS bench 23.5% · 1Y 135.2%8 of 12 weeks ahead 100% evidence |
| Exact sum: 24.5 + 11.3 + 5.6 + 18.5 = 59.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5The J. M. Smucker CompanySJM | 59.7/100Mixed-positive evidence64% evidence | BREAKING OUT | 22.5/35 Revenue 3.7% · PAT — · OPM change 47.5 pp 62% evidence | 12.9/25 ROCE 3.1% · OPM 19.6% 76% evidence | 9.1/20 P/E 23× · PEG — 15% evidence | 15.2/20 RS sector 7.9% · RS bench 0.9% · 1Y 7.6%7 of 12 weeks ahead 100% evidence |
| Exact sum: 22.5 + 12.9 + 9.1 + 15.2 = 59.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6John B. Sanfilippo & Son, Inc.JBSS | 58.8/100Thin evidence · provisional60% evidence | TURNING | 16.6/35 Revenue 5.1% · PAT 21.4% · OPM change -2.4 pp 53% evidence | 13.8/25 ROCE 5.2% · OPM 8.4% 57% evidence | 13.9/20 P/E 13.6× · PEG 0.67 65% evidence | 14.5/20 RS sector 8.5% · RS bench 2% · 1Y 34%0 of 12 weeks ahead 70% evidence |
| Exact sum: 16.6 + 13.8 + 13.9 + 14.5 = 58.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7The Campbell's CompanyCPB | 56.0/100Mixed-positive evidence81% evidence | TURNING | 22.1/35 Revenue -2.9% · PAT 33.9% · OPM change 3.6 pp 83% evidence | 11.8/25 ROCE 2% · OPM 10.1% 76% evidence | 15.2/20 P/E 10.3× · PEG 0.3 65% evidence | 6.9/20 RS sector -16.8% · RS bench -23.1% · 1Y -29.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 22.1 + 11.8 + 15.2 + 6.9 = 56 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Smithfield Foods, Inc.SFD | 51.3/100Mixed-positive evidence66% evidence | BASING | 17.4/35 Revenue 7.5% · PAT 12.1% · OPM change 0.3 pp 53% evidence | 13.4/25 ROCE 3.1% · OPM 8.8% 57% evidence | 13.5/20 P/E 10.4× · PEG 0.96 65% evidence | 7.0/20 RS sector -0.8% · RS bench -7% · 1Y -0.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 17.4 + 13.4 + 13.5 + 7 = 51.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Lamb Weston Holdings, Inc.LW | 50.6/100Thin evidence · provisional56% evidence | TURNING | 14.9/35 Revenue — · PAT — · OPM change -8.3 pp 39% evidence | 12.0/25 ROCE 2.8% · OPM 8.1% 76% evidence | 9.5/20 P/E 20.8× · PEG — 15% evidence | 14.2/20 RS sector 2.4% · RS bench -4.8% · 1Y 3.2%3 of 12 weeks ahead 100% evidence |
| Exact sum: 14.9 + 12 + 9.5 + 14.2 = 50.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10Utz Brands, Inc.UTZ | 50.4/100Thin evidence · provisional56% evidence | TURNING | 14.7/35 Revenue 2.3% · PAT -144.1% · OPM change 0.6 pp 53% evidence | 7.3/25 ROCE 0.3% · OPM 2.2% 57% evidence | 8.5/20 P/E 1046× · PEG — 15% evidence | 19.9/20 RS sector 37.4% · RS bench 27% · 1Y 10.5%3 of 12 weeks ahead 100% evidence |
| Exact sum: 14.7 + 7.3 + 8.5 + 19.9 = 50.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11JBS N.V.JBS | 47.6/100Thin evidence · provisional60% evidence | BASING | 15.5/35 Revenue 12.1% · PAT -11.3% · OPM change -2.3 pp 53% evidence | 9.6/25 ROCE 1.5% · OPM 2.2% 57% evidence | 15.5/20 P/E 11.3× · PEG 0.16 65% evidence | 7.0/20 RS sector -9.9% · RS bench -16% · 1Y -4.8%0 of 12 weeks ahead 70% evidence |
| Exact sum: 15.5 + 9.6 + 15.5 + 7 = 47.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12The Kraft Heinz CompanyKHC | 47.0/100Thin evidence · provisional56% evidence | TURNING | 13.4/35 Revenue -1.8% · PAT -317% · OPM change -1 pp 53% evidence | 11.4/25 ROCE 1.5% · OPM 18.9% 57% evidence | 9.9/20 P/E 13.8× · PEG — 15% evidence | 12.3/20 RS sector 4.2% · RS bench -2.7% · 1Y -4%4 of 12 weeks ahead 100% evidence |
| Exact sum: 13.4 + 11.4 + 9.9 + 12.3 = 47 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Hormel Foods CorporationHRL | 46.3/100Mixed-negative evidence71% evidence | BREAKING OUT | 13.1/35 Revenue 2.5% · PAT -37.6% · OPM change -1.3 pp 83% evidence | 10.7/25 ROCE 1.8% · OPM 7.3% 76% evidence | 8.9/20 P/E 25.4× · PEG — 15% evidence | 13.6/20 RS sector 2% · RS bench -4.9% · 1Y -11%5 of 12 weeks ahead 100% evidence |
| Exact sum: 13.1 + 10.7 + 8.9 + 13.6 = 46.3 · Decision use: Price leads the evidence: RS versus the benchmark is -4.9%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 14Ingredion IncorporatedINGR | 45.4/100Mixed-negative evidence66% evidence | BASING | 14.4/35 Revenue -2.2% · PAT 7.2% · OPM change -3.9 pp 53% evidence | 14.0/25 ROCE 3.1% · OPM 11.3% 57% evidence | 12.5/20 P/E 10.9× · PEG 1.14 65% evidence | 4.5/20 RS sector -10.3% · RS bench -16.5% · 1Y -17.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14.4 + 14 + 12.5 + 4.5 = 45.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15McCormick & Company, IncorporatedMKC | 45.3/100Mixed-negative evidence81% evidence | TURNING | 18.4/35 Revenue 9.5% · PAT 1.1% · OPM change -0.5 pp 83% evidence | 14.2/25 ROCE 2.4% · OPM 14.3% 76% evidence | 6.7/20 P/E 7.9× · PEG 4.94 65% evidence | 6.0/20 RS sector -16.9% · RS bench -23% · 1Y -26%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.4 + 14.2 + 6.7 + 6 = 45.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16BellRing Brands, Inc.BRBR | 45.3/100Thin evidence · provisional60% evidence | TURNING | 13.0/35 Revenue 6.4% · PAT -43.6% · OPM change -5.2 pp 53% evidence | 15.5/25 ROCE 9.2% · OPM 11% 57% evidence | 13.8/20 P/E 12.5× · PEG 0.7 65% evidence | 3.0/20 RS sector -45.3% · RS bench -50.3% · 1Y -67.3%1 of 12 weeks ahead 70% evidence |
| Exact sum: 13 + 15.5 + 13.8 + 3 = 45.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 17Freshpet, Inc.FRPT | 45.1/100Mixed-negative evidence61% evidence | TURNING | 20.5/35 Revenue 12.1% · PAT 100% · OPM change 5.9 pp 40% evidence | 6.9/25 ROCE 0.3% · OPM 1.5% 57% evidence | 5.3/20 P/E 15.8× · PEG 2.98 65% evidence | 12.4/20 RS sector 0% · RS bench -6.8% · 1Y -0.6%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20.5 + 6.9 + 5.3 + 12.4 = 45.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Nomad Foods LimitedNOMD | 43.7/100Thin evidence · provisional60% evidence | BREAKING OUT | 13.3/35 Revenue -2.9% · PAT -40.9% · OPM change -1.8 pp 53% evidence | 10.3/25 ROCE 1.1% · OPM 7.9% 57% evidence | 11.5/20 P/E 9.3× · PEG 1.49 65% evidence | 8.6/20 RS sector -2.1% · RS bench -9.2% · 1Y -26.3%6 of 12 weeks ahead 70% evidence |
| Exact sum: 13.3 + 10.3 + 11.5 + 8.6 = 43.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 19The Marzetti CompanyMZTI | 40.7/100Mixed-negative evidence66% evidence | BASING | 15.8/35 Revenue 2.8% · PAT 3.5% · OPM change -0.6 pp 53% evidence | 13.4/25 ROCE 4.1% · OPM 10.3% 57% evidence | 8.7/20 P/E 21.6× · PEG 1.71 65% evidence | 2.8/20 RS sector -28.7% · RS bench -34.2% · 1Y -38.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.8 + 13.4 + 8.7 + 2.8 = 40.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Conagra Brands, Inc.CAG | 39.8/100Thin evidence · provisional56% evidence | TURNING | 15.5/35 Revenue — · PAT — · OPM change 1.6 pp 39% evidence | 6.8/25 ROCE -10.8% · OPM 10% 76% evidence | 10.6/20 P/E 11.2× · PEG — 15% evidence | 6.9/20 RS sector -13.1% · RS bench -19.4% · 1Y -22.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 15.5 + 6.8 + 10.6 + 6.9 = 39.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 21Post Holdings, Inc.POST | 38.8/100Mixed-negative evidence66% evidence | BASING | 18.5/35 Revenue 7.2% · PAT -5% · OPM change 1.1 pp 53% evidence | 11.6/25 ROCE 1.8% · OPM 10.4% 57% evidence | 5.6/20 P/E 16.6× · PEG 2.92 65% evidence | 3.1/20 RS sector -13.8% · RS bench -19.6% · 1Y -16.1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.5 + 11.6 + 5.6 + 3.1 = 38.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Flowers Foods, Inc.FLO | 38.3/100Thin evidence · provisional56% evidence | ASLEEP | 16.9/35 Revenue — · PAT — · OPM change -0.4 pp 39% evidence | 10.1/25 ROCE 2.3% · OPM 5.1% 76% evidence | 9.4/20 P/E 21.5× · PEG — 15% evidence | 1.9/20 RS sector -31.3% · RS bench -36.7% · 1Y -55.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.9 + 10.1 + 9.4 + 1.9 = 38.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 23Pilgrim's Pride CorporationPPC | 33.7/100Thin evidence · provisional56% evidence | BASING | 12.8/35 Revenue — · PAT — · OPM change -5.5 pp 39% evidence | 8.7/25 ROCE 0.9% · OPM 3.6% 76% evidence | 10.2/20 P/E 12.5× · PEG — 15% evidence | 2.0/20 RS sector -29.2% · RS bench -34.5% · 1Y -46%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12.8 + 8.7 + 10.2 + 2 = 33.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 24J&J Snack Foods Corp.JJSF | 33.4/100Thin evidence · provisional60% evidence | BASING | 14.6/35 Revenue -2.1% · PAT -23.7% · OPM change -1.2 pp 53% evidence | 9.0/25 ROCE 0.2% · OPM 0.5% 57% evidence | 3.8/20 P/E 26.8× · PEG 6.43 65% evidence | 6.0/20 RS sector -13.2% · RS bench -19.5% · 1Y -28.1%0 of 12 weeks ahead 70% evidence |
| Exact sum: 14.6 + 9 + 3.8 + 6 = 33.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 25General Mills, Inc.GIS | 27.7/100Adverse evidence71% evidence | BASING | 5.8/35 Revenue -5.4% · PAT -103.7% · OPM change -56.5 pp 83% evidence | 6.5/25 ROCE -8.6% · OPM -45.4% 76% evidence | 10.7/20 P/E 10.9× · PEG — 15% evidence | 4.7/20 RS sector -17.9% · RS bench -24% · 1Y -27.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 5.8 + 6.5 + 10.7 + 4.7 = 27.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26The Simply Good Foods CompanySMPL | 23.6/100Adverse evidence65% evidence | ASLEEP | 5.4/35 Revenue -4.5% · PAT -237.2% · OPM change -29.6 pp 83% evidence | 5.7/25 ROCE -2.3% · OPM -14% 76% evidence | 9.2/20 P/E 21.9× · PEG — 15% evidence | 3.3/20 RS sector -38.1% · RS bench -43.3% · 1Y -61.5%1 of 12 weeks ahead 70% evidence |
| Exact sum: 5.4 + 5.7 + 9.2 + 3.3 = 23.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27Westrock Coffee CompanyWEST | 52.8/100Thin evidence · provisional48% evidence | ASLEEP | 21.7/35 Revenue 47.3% · PAT — · OPM change 7.1 pp 40% evidence | 7.1/25 ROCE 0.4% · OPM 1% 57% evidence | 10.0/20 P/E — · PEG — 0% evidence | 14.0/20 RS sector 34.5% · RS bench 27.8% · 1Y 14.2%11 of 12 weeks ahead 100% evidence |
| Exact sum: 21.7 + 7.1 + 10 + 14 = 52.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 28Herbalife Ltd.HLF | 51.3/100Thin evidence · provisional50% evidence | ASLEEP | 17.6/35 Revenue 3.7% · PAT -15% · OPM change 0.4 pp 53% evidence | 14.8/25 ROCE 8.1% · OPM 10.5% 57% evidence | 11.5/20 P/E 6.5× · PEG — 15% evidence | 7.4/20 RS sector -4.9% · RS bench -10.8% · 1Y 43.8%0 of 12 weeks ahead 70% evidence |
| Exact sum: 17.6 + 14.8 + 11.5 + 7.4 = 51.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 29Once Upon A Farm, PBCOFRM | 45.1/100Thin evidence · provisional28% evidence | FADING | 19.6/35 Revenue 48.6% · PAT — · OPM change -4 pp 40% evidence | 5.5/25 ROCE -15.8% · OPM -22.2% 57% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y —4 of 12 weeks ahead 0% evidence |
| Exact sum: 19.6 + 5.5 + 10 + 10 = 45.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 30The Magnum Ice Cream Company N.V.this pageMICC | 44.6/100Thin evidence · provisional18% evidence | BREAKING OUT | 16.7/35 Revenue — · PAT — · OPM change — 9% evidence | 9.2/25 ROCE 0.4% · OPM — 46% evidence | 8.7/20 P/E 28.1× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —6 of 12 weeks ahead 0% evidence |
| Exact sum: 16.7 + 9.2 + 8.7 + 10 = 44.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is The Magnum Ice Cream Company N.V.'s stock price today?
The Magnum Ice Cream Company N.V. trades at $18.3. The company is valued at $11.0 B. The stock sits at 84% of its 52-week range of $13–$19. Against the S&P 500 it has been ahead on a trailing-13-week view for 7 weeks. — as of 5 August 2026.
What were The Magnum Ice Cream Company N.V.'s latest quarterly results?
The Magnum Ice Cream Company N.V. reported revenue of $3.4 B and a net loss of $0.2 B for the Dec 25 quarter. Revenue fell 3.9% and profit fell 223.1% year on year. Earnings per share were $−0.26. The operating margin was 0.9%, 3.6 pp lower than a year earlier. — as of 5 August 2026.
What is The Magnum Ice Cream Company N.V.'s revenue?
The Magnum Ice Cream Company N.V. reported revenue of $3.4 B in the Dec 25 quarter, −3.9% year on year. For the full FY25 fiscal year, revenue was $7.9 B (−0.5%). Over the last 3 years revenue compounded at 1.7% a year. — as of 5 August 2026.
What is The Magnum Ice Cream Company N.V.'s profit?
The Magnum Ice Cream Company N.V. earned $−0.2 B of net profit in the Dec 25 quarter, −223.1% year on year. Full-year FY25 profit was $0.3 B. The operating margin ran 0.9% in the latest quarter. — as of 5 August 2026.
What is The Magnum Ice Cream Company N.V.'s market cap?
The Magnum Ice Cream Company N.V.'s market capitalisation is $11.0 B at a stock price of $18.3. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
Does The Magnum Ice Cream Company N.V. pay a dividend?
No — The Magnum Ice Cream Company N.V. has declared no dividend per share in any of its last 4 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.
Is The Magnum Ice Cream Company N.V. growing?
Not right now — The Magnum Ice Cream Company N.V.'s latest numbers are shrinking: latest-quarter revenue −3.9% year on year, profit −223.1%, and the margin −3.6 pp at 0.9%. The 3-year compound rates are 1.7% (revenue) and −16.4% (profit). The earnings engine currently reads: deteriorating — as of 5 August 2026.
How is The Magnum Ice Cream Company N.V. performing?
The Magnum Ice Cream Company N.V.'s latest readings are below. Its latest quarter's revenue fell 3.9% and profit fell 223.1% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 7 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
Is The Magnum Ice Cream Company N.V. beating the market?
On recent form, yes — The Magnum Ice Cream Company N.V. has been ahead of the S&P 500 on a trailing-13-week view for 7 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 7 months the stock moved +15% against the S&P 500's +13% — ahead of the index over the full window. — as of 5 August 2026.
Will The Magnum Ice Cream Company N.V.'s stock price go up?
This page publishes no price forecast for The Magnum Ice Cream Company N.V. What it measures instead: the stock price is $18.3. Direction is not something this site claims to know. — as of 5 August 2026.
Is the market betting against The Magnum Ice Cream Company N.V.?
Somewhat — short interest is 2.5% of The Magnum Ice Cream Company N.V.'s tradable float, about 7.8 days to cover at typical volumes. A moderate reading: some money is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
Does The Magnum Ice Cream Company N.V. have too much debt?
It carries real leverage — The Magnum Ice Cream Company N.V.'s debt-to-equity is 3.43. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.
What is The Magnum Ice Cream Company N.V.'s capex?
The Magnum Ice Cream Company N.V. spent $1.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.4 B. — as of 5 August 2026.
What is The Magnum Ice Cream Company N.V.'s cash flow?
The Magnum Ice Cream Company N.V. generated $0.5 B of operating cash flow in FY25 and $0.1 B of free cash flow after $0.4 B of capital spending. Reported profit that year was $0.3 B, so operating cash ran ahead of profit. — as of 5 August 2026.
Is The Magnum Ice Cream Company N.V.'s profit real cash?
Yes — over the last 3 fiscal years, 177% of The Magnum Ice Cream Company N.V.'s reported profit arrived as operating cash. In FY25, operating cash was $0.5 B against reported profit of $0.3 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.
How financially safe is The Magnum Ice Cream Company N.V.?
On the balance sheet, the Z-score reads 1.75 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is inside the danger band — a real balance-sheet risk. — as of 5 August 2026.
Where is The Magnum Ice Cream Company N.V. in its business cycle?
The Magnum Ice Cream Company N.V.'s FY25 operating margin was 7.6%, against a 4-year band of 7.6%–9.9%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 0.9%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the The Magnum Ice Cream Company N.V. story?
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is The Magnum Ice Cream Company N.V. a stock worth studying right now?
This is not investment advice. The machine read: The Magnum Ice Cream Company N.V.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.